# Gut microbiota affects the progression of colorectal cancer under the intervention of exercise

**Authors:** Linlin Tao, Huan Zhou, Wenjiao Shao, Dongmei Liu, Yingwen Ruan, Mingwei Chen

PMC · DOI: 10.3389/fmicb.2026.1728541 · Frontiers in Microbiology · 2026-02-05

## TL;DR

Exercise slows colorectal cancer progression by improving gut bacteria balance and reducing inflammation.

## Contribution

This study reveals how exercise modulates gut microbiota and metabolites to inhibit CRC progression in rats.

## Key findings

- Exercise increases beneficial gut bacteria like Bifidobacterium and decreases harmful ones like Escherichia-Shigella.
- Exercise restores intestinal barrier function and reduces inflammation in CRC rats.
- Exercise suppresses CRC progression by balancing gut flora-metabolite interactions.

## Abstract

Colorectal cancer (CRC) ranks as the third most common cancer globally, accounting for 10% of cases, and is the second leading cause of cancer-related death. Exercise can maintain/restore the body’s internal balance at multiple levels to prevent pathologies, although its mechanism is complex and involves multiple systems. While physical activity improves colon cancer patients’ quality of life and reduces discomfort, how it works remains unclear. To explore this, we constructed a rat CRC model. We performed 16S rRNA and nontargeted metabolomics sequencing and analyzed the results to screen distinct intestinal microbes and their metabolites. To clarify the links among these microbes/metabolites, intestinal barrier function, and inflammatory markers, we used qRT–PCR, immunohistochemistry, and ELISA to verify the effects of exercise intervention on intestinal barrier function and inflammatory factor expression. We also checked the expression of the PCNA gene (a proliferation index) to assess cell proliferation. In vivo, different exercise interventions hindered DMH-induced colon cancer progression in rats and reshaped the gut microbiota. They increase the number of beneficial bacteria, such as Bifidobacterium, and reduce the number of harmful bacteria, such as Escherichia-Shigella. Compared with the Model group, exercise restored intestinal barrier function, promoted anti-inflammatory factor expression, and suppressed proinflammatory factor expression by regulating the gut flora. Overall, exercise intervention curbs CRC development by modulating gut flora–metabolite interactions, restoring the intestinal barrier, and adjusting inflammatory expression. This study confirms the inhibitory effect of exercise on CRC progression. These findings show that different intensities of exercise can impact CRC intestinal barrier function and inflammatory factor levels by balancing the gut flora and metabolites, suggesting a new CRC prevention/treatment approach.

## Linked entities

- **Genes:** PCNA (proliferating cell nuclear antigen) [NCBI Gene 5111]
- **Chemicals:** DMH (PubChem CID 1322)
- **Diseases:** colorectal cancer (MONDO:0005575), CRC (MONDO:0005575)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** Muc2 (mucin 2, oligomeric mucus/gel-forming) [NCBI Gene 24572] {aka AABR07006030.1, HH-Muc, MLP}, Il10 (interleukin 10) [NCBI Gene 25325] {aka IL10X, If2a}, Il6 (interleukin 6) [NCBI Gene 24498] {aka ILg6, Ifnb2}, Pcna (proliferating cell nuclear antigen) [NCBI Gene 25737] {aka PCNAR, Pcna/cyclin}, Tnf (tumor necrosis factor) [NCBI Gene 24835] {aka RATTNF, TNF-alpha, Tnfa}, Il1b (interleukin 1 beta) [NCBI Gene 24494] {aka IL-1F2}, Ocln (occludin) [NCBI Gene 83497], Cldn1 (claudin 1) [NCBI Gene 65129]
- **Diseases:** shortening (MESH:C535850), intestinal damage (MESH:D007410), CRC (MESH:D015179), death (MESH:D003643), hypercholesterolemic (MESH:D006938), cytotoxic (MESH:D064420), obesity (MESH:D009765), weight gain (MESH:D015430), carcinogenesis (MESH:D063646), colon inflammation (MESH:D007249), dysplasia (MESH:D015792), Dysbiosis (MESH:D064806), cancer (MESH:D009369), adenocarcinoma (MESH:D000230)
- **Chemicals:** butyric acid (MESH:D020148), agarose (MESH:D012685), LPS (MESH:D008070), lipid (MESH:D008055), DMH (MESH:D004111), alcohol (MESH:D000438), eosin (MESH:D004801), 3,3'-diaminobenzidine (MESH:D015100), SCFA (MESH:D005232), 2,3-butanedione (MESH:D003931), trehalose (MESH:D014199), bile acid (MESH:D001647), H&amp;E (MESH:D006371), raffinose (MESH:D011887), hydrogen peroxide (MESH:D006861), 2-methoxycinnamic acid (-), sodium (MESH:D012964), glycerol (MESH:D005990), DMH (MESH:D004127), hematoxylin (MESH:D006416), sodium citrate (MESH:D000077559), CTAB (MESH:D000077286), methyl linoleate (MESH:C005575), amino acid (MESH:D000596), Prolyl-Tyrosine (MESH:C074016), aspartic acid (MESH:D001224), butyrate (MESH:D002087), carbohydrate (MESH:D002241), arginine (MESH:D001120), fatty acid (MESH:D005227), phenylalanine (MESH:D010649), tyrosine (MESH:D014443), phospholipid (MESH:D010743), propionic acid (MESH:C029658), stearic acid (MESH:C031183), glutamate (MESH:D018698), ethanol (MESH:D000431), proline (MESH:D011392), linoleic acid (MESH:D019787), deoxycholic acid (MESH:D003840), pyruvate (MESH:D019289), inosine (MESH:D007288), TDCA (MESH:D013657), Paraffin (MESH:D010232), succinic acid (MESH:D019802), 3-hydroxydodecanoic acid (MESH:C022145), formic acid (MESH:C030544), glycerophospholipids (MESH:D020404), isoleucine (MESH:D007532), lactic acid (MESH:D019344), xylene (MESH:D014992), 20-hydroxyeicosatetraenoic acid (MESH:C055987), tricarboxylic acid (MESH:D014233), alanine (MESH:D000409), betulinic acid (MESH:D000094062), acetonitrile (MESH:C032159), agar (MESH:D000362)
- **Species:** Shigella (genus) [taxon 620], Bacillota (clostridial firmicutes, phylum) [taxon 1239], Parasutterella (genus) [taxon 577310], Fusobacterium nucleatum (species) [taxon 851], Streptococcus (genus) [taxon 1301], Eubacterium ruminantium (species) [taxon 42322], Bacteroides (genus) [taxon 816], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Rattus norvegicus (brown rat, species) [taxon 10116], Muribaculum (genus) [taxon 1918540], Bifidobacterium (genus) [taxon 1678], Clostridioides difficile (species) [taxon 1496], Homo sapiens (human, species) [taxon 9606], Clostridium (genus) [taxon 1485], Dubosiella (genus) [taxon 1937008], Eggerthella lenta (species) [taxon 84112], Clostridia (class) [taxon 186801], Romboutsia (genus) [taxon 1501226], Nicotiana tabacum (American tobacco, species) [taxon 4097], Escherichia coli (E. coli, species) [taxon 562], Mus musculus (house mouse, species) [taxon 10090], Coprococcus (genus) [taxon 33042], Prevotella (genus) [taxon 838], Lactobacillus (genus) [taxon 1578], Listeria (genus) [taxon 1637]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12916588/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12916588/full.md

## References

33 references — full list in the complete paper: https://tomesphere.com/paper/PMC12916588/full.md

---
Source: https://tomesphere.com/paper/PMC12916588